Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Critical Path Institute is an independent nonprofit that accelerates drug development by leading global collaborations among regulators, industry, academia, patient groups, and foundations. It creates regulatory-endorsed biomarkers, clinical trial simulation models/tools, aggregated clinical trial databases for research use in multiple diseases/therapeutic areas. Its work has contributed to new treatments/regulatory approvals in tuberculosis and polycystic kidney disease as well as improved trial design in Alzheimer’s.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Critical Path Institute.